A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

March 1, 2033

Study Completion Date

March 1, 2033

Conditions
Cancer
Interventions
DRUG

Ipatasertib

Ipatasertib will be administered as a monotherapy at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants discontinuation from the parent study.

DRUG

Tiragolumab

Tiragolumab in combination with atezolizumab will be administered at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants discontinuation from the parent study.

DRUG

Atezolizumab

Atezolizumab will be administered as a monotherapy and in combination at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants' discontinuation from the parent study.

DRUG

Tiragolumab and Atezolizumab

Tiragolumab and Atezolizumab in fixed dose combination administered intravenously (IV) at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants discontinuation from the parent study.

DRUG

Bevacizumab

Bevacizumab will be administered as a monotherapy or in combination with atezolizumab at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants discontinuation from the parent study.

DRUG

Entrectinib

Entrectinib will be administered as a monotherapy at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants discontinuation from the parent study.

DRUG

Inavolisib

Inavolisib will be administered as a monotherapy or in combination at the same dose, schedule, and with the same administration guidelines that were in effect at the time of participants discontinuation from the parent study.

Trial Locations (40)

110

RECRUITING

National Taiwan University Hospital, Taipei

333

ACTIVE_NOT_RECRUITING

Chang Gung Memorial Hospital - Linkou, Taoyuan District

407

RECRUITING

Taichung Veterans General Hospital, Taichung

3000

RECRUITING

UZ Leuven Gasthuisberg, Leuven

6060

COMPLETED

GHdC Site Les Viviers, Charleroi

8500

ACTIVE_NOT_RECRUITING

AZ Groeninge, Kortrijk

10103

ACTIVE_NOT_RECRUITING

Clinica CIMCA, San José

10108

ACTIVE_NOT_RECRUITING

ICIMED Instituto de Investigación en Ciencias Médicas, San José

10330

ACTIVE_NOT_RECRUITING

Chulalongkorn Hospital, Bangkok

10700

RECRUITING

Siriraj Hospital, Bangkok

14076

RECRUITING

Centre Francois Baclesse, Caen

21000

RECRUITING

Institut de Cancérologie de Bourgogne, Dijon

30029

ACTIVE_NOT_RECRUITING

Institut de cancerologie du Gard, Nîmes

34000

ACTIVE_NOT_RECRUITING

Consultorio de Especialidad en Urologia Privado, Durango

34298

RECRUITING

Centre Régional de Lutte Contre Le Cancer Val D'aurelle Paul Lamarque, Montpellier

44805

RECRUITING

ICO - Site René Gauducheau, Saint-Herblain

50200

ACTIVE_NOT_RECRUITING

Maharaj Nakorn Chiangmai Hospital, Chiang Mai

97070

RECRUITING

Medical Care & Research, Mérida

100142

RECRUITING

Beijing Cancer Hospital, Beijing

117997

ACTIVE_NOT_RECRUITING

Russian Scientific Center of Roentgenoradiology, Moscow

125248

RECRUITING

P.A. Herzen Oncological Inst., Moscow

143423

RECRUITING

Moscow City Oncology Hospital #62, Moscovskaya Oblast

210029

RECRUITING

Jiangsu Province Hospital of Chinese Medicine, Nanjing

230601

RECRUITING

The Second Affiliated Hospital of Anhui Medical University, Hefei

310016

RECRUITING

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou

361003

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

514031

RECRUITING

Meizhou People's Hospital, Meizhou

M5G 1Z5

RECRUITING

Princess Margaret Cancer Center, Toronto

DUMMY_VALUE

RECRUITING

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

570 10

RECRUITING

"General Hospital G.Papanikolaou", Asvestochóri

155 62

RECRUITING

Metropolitan General Hospital, Cholargós

812-8582

RECRUITING

Kyushu University Hospital, Fukuoka

232-0024

ACTIVE_NOT_RECRUITING

Yokohama City University Medical Center, Kanagawa

241-8515

COMPLETED

Kanagawa Cancer Center, Kanagawa

362-0806

RECRUITING

Saitama Cancer Center, Saitama

Unknown

ACTIVE_NOT_RECRUITING

Centro Medico Culiacan SA de CV, Culiacán

463-707

ACTIVE_NOT_RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

05505

ACTIVE_NOT_RECRUITING

Asan Medical Center, Seoul

LE1 5WW

RECRUITING

Leicester Royal Infirmary, Leicester

SM2 5PT

RECRUITING

Royal Marsden Hospital - Surrey, Surrey

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY